Mikra Introduces Serenity, an Innovative Mental Health Product for Anxiety, Available for Purchase on Black Friday
16 Novembre 2023 - 1:00PM
Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech
company that leverages advancements in science and technology to
build breakthrough ventures that transform human wellness, is
pleased to announce that its U.S. biosciences subsidiary Mikra
Cellular Sciences Inc. (“Mikra”) will offer
Serenity, a natural supplement whose active
ingredient has been clinically studied for supporting symptoms of
anxiety, for sale at weareMikra.com a month ahead of schedule in
late November. Customers are invited to sign up for updates and
promotional offers at https://bit.ly/serenity-sign-up.
"We are delighted to bring Serenity to market
ahead of schedule and in time for Black Friday, the busiest
shopping day of the year," said Meni Morim, CEO of Lifeist.
"Serenity ships with a full 30-day supply in every
bottle, as compared to the typical 7- or 14-day supply sold in
competing lavender-based products. We are confident that our value
proposition, combined with a consistent GCMS-verified dose1 of the
active ingredient and the gentle flavor profile provided by our
proprietary polyterpene blend, will offer customers an attractive
natural alternative -- powered by science2 -- to counter
anxiety."
The active ingredient in Serenity is a steam
extract of lavender oil which has been extensively clinically
studied as a frontline solution to anxiety. In a randomized,
double-blind clinical trial it out-performed paroxetine (PaxilTM),
a frontline SSRI prescribed for the management of generalized
anxiety disorder. The same study also concluded that lavender oil
extract: "...is efficacious and well tolerated in patients with
(generalize anxiety disorder) GAD... [and] can be terminated after
10 weeks of treatment with the full therapeutic dose without
down-titration and without causing symptoms of withdrawal."2
Mikra is pushing biosciences beyond the expected with the belief
that it is possible to add more vigorous, active, valuable and
enjoyable years to your life through protecting and maintaining
your cellular health. Lifeist looks forward to bringing this
innovative solution to market, and to continuing to build a robust,
science-based pipeline of products in 2024.
About Lifeist Wellness
Inc. Sitting at the forefront of the
post-pandemic wellness revolution, Lifeist leverages advancements
in science and technology to build breakthrough companies that
transform human wellness. Portfolio business units include:
CannMart, which operates a B2B wholesale distribution business
facilitating recreational cannabis sales to Canadian provincial
government control boards including for CannMart Labs, a BHO
extraction facility producing high margin cannabis 2.0 products;
Australian Vapes, one of Australia’s largest online retailers of
vaporizers and accessories; and Mikra, a biosciences and consumer
wellness company developing and selling innovative therapies for
cellular health. Information on Lifeist and its businesses can
be accessed through the links below:
www.lifeist.com https://cannmart.com https://www.roilty.cohttps://wearemikra.com www.australianvaporizers.com.au
Contact: Meni
Morim CEO Lifeist Wellness Inc. Ph:
647-362-0390 Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press
release.
Forward Looking
Information This news release contains
“forward-looking information” within the meaning of applicable
securities laws. All statements contained herein that are not
historical in nature contain forward-looking information.
Forward-looking information can be identified by words or phrases
such as “may”, “expect”, “likely”, “should”, “would”, “plan”,
“anticipate”, “intend”, “potential”, “proposed”, “estimate”,
“believe” or the negative of these terms, or other similar words,
expressions and grammatical variations thereof, or statements that
certain events or conditions “may” or “will”
happen.
The forward-looking information contained
herein, including, without limitation, statements related to the
expected date that Serenity will be available for sale, the
anticipated benefits of Serenity in enhancing mental well-being and
countering anxiety in particular and the anticipated development of
additional products in 2024 are made as of the date of this news
release and are based on assumptions management believed to be
reasonable at the time such statements were made, including without
limitation, expectations that the production of Serenity as well as
additional products is successfully completed as anticipated, the
effectiveness of lavender oil and its extracts in treating anxiety
as demonstrated in published materials and studies, its expectation
that the nutraceutical market will develop as currently
anticipated, the nutraceutical market will continue to be a
multi-billion dollar high-margin market, expectations that Serenity
will gain market acceptance as a natural supplement alternative for
the treatment of anxiety, along with the expansion of the market
for nutraceutical products, as well as other considerations that
are believed to be appropriate in the circumstances. While we
consider these assumptions to be reasonable based on information
currently available to management, there is no assurance that such
expectations will prove to be correct. By its nature,
forward-looking information is subject to inherent risks and
uncertainties that may be general or specific and which give rise
to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct, and that objectives, strategic
goals and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this news release. Such factors
include, without limitation: the failure to successfully complete
production of, and make available for sale, Serenity as anticipated
and in a timely manner as well as other products in the future, the
failure of Serenity, a natural supplement alternative, to
demonstrate a notable effectiveness in treating general anxiety
disorder or other anticipated health benefits, the inability of the
Company to develop Mikra’s business as anticipated, unanticipated
changes to current regulations that would adversely impact Mikra’s
business, unforeseen developments that would delay Mikra’s ability
to sell Serenity and other nutraceutical products, the risk that
the expected demand for nutraceutical products in general and those
of Mikra in particular does not develop as anticipated and risks
relating to the Company’s ability to execute its business strategy
and the benefits realizable therefrom. Additional risk factors can
also be found in the Company’s current MD&A filed under the
Company’s SEDAR profile at www.sedarplus.ca. Readers are
cautioned not to put undue reliance on forward-looking information.
The Company undertakes no obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable law. Forward-looking statements contained in this news
release are expressly qualified by this cautionary statement.
Source: Lifeist Wellness Inc.
1 GCMS-verified doses have been rigorously confirmed through Gas
Chromatography-Mass Spectrometry analysis, and provide a high level
of confidence in the accuracy and reliability of the specified
dosage, making it a crucial aspect of quality control in industries
where precise and consistent dosing is essential for safety and
efficacy.
2 Lavender oil preparation is effective in generalized anxiety
disorder - https://pubmed.ncbi.nlm.nih.gov/24456909/
TM All referenced trademarks are the property of their
respective owners.
Grafico Azioni Lifeist Wellness (TSXV:LFST)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Lifeist Wellness (TSXV:LFST)
Storico
Da Mag 2023 a Mag 2024